Eli Lilly-backed cancer drug developer Cerulean Pharma priced its initial public offering at $7.00, considerably below the range originally set.
Month: April 2014
Piramal gets healthy return from Vodafone India investment
The healthcare company made a 52% profit from the sale of its 11% stake, originally acquired in 2012, back to Vodafone for $1.48bn.
Minerva seeks divine outcome in $69m IPO
The Proteosys-backed pharmaceutical company, formed through a merger last year, is also set to raise $26m from a concurrent private placement to Johnson & Johnson.
Mahindra CIE to hook up with Japanese firms for Southeast Asia venture
The Spanish-Indian partnership is in talks with two Japan-based firms over a tripartite venture that would seek acquisitions and ventures in Southeast Asia.
Mayo Clinic and Enterprise Ireland come together in $16m collaboration
The Irish government agency will invest up to $16m in the Mayo-backed venture, which will aim to commercialise US medical technology at Irish universities.
Ybrant takes minority stake in online recruiter Jobookit
The India-based digital marketer is set to invest in Jobookit, which has already secured $4m in earlier rounds.
NXP Semiconductors touches Senseg for $6m series B
Senseg, which is developing technology for touchscreen interfaces, has secured $6m in a series B round supported by NXP.
ESB Novusmodus goes back for more with second investment in Aveillant
UK-based Aveillant has now raised about $21.7m from investors including ESB and original parent company Cambridge Consultants.
CymaBay becomes latest biopharma company to file for an IPO
The US-based metabolic disease treatment developer has raised $165m since 2002, but plans to raise only $30m when it goes public.
Cargill sails up to Rivertop Renewables
The renewable chemicals producer has raised $26m in a round that takes its overall equity funding to almost $30m.
Novartis invests in $200m China-based life sciences fund
Life sciences-focused private equity firm BVCF has completed a third fund that will target China-based investments, and Novartis is amongst the backers.
Flipkart rides in for $330m Myntra acquisition
The merger between the two India-based e-commerce companies, which are backed by corporates including IDG and Naspers, values lifestyle retailer Myntra at about $330m.
Small business marketing app Closely raises $3m
Comcast is among the investors in Closely’s $3m series A, which brings its total equity funding to $6.6m.
AdvanDx looks to expand with $12m investment
AdvanDx, which develops treatments to combat hospital infections, has secured $12m in its latest round, which included pharmaceutical company Merck.